Brief: CareDx Submits Comment Letter On Draft LCD For Molecular Testing For Solid Organ Transplant Rejection
02/09/2025 22:37
Sept 2 (Reuters) - CareDx Inc CDNA.O: CAREDX- SUBMITS COMMENT LETTER ON DRAFT LCD FOR MOLECULAR TESTING FOR SOLID ORGAN TRANSPLANT REJECTION Source text: ID:nBw4TBHR6a Further company coverage: CDNA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23